Guidelines of care for the management of cutaneous squamous cell carcinoma

J Am Acad Dermatol. 2018 Mar;78(3):560-578. doi: 10.1016/j.jaad.2017.10.007. Epub 2018 Jan 10.

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.

Keywords: biopsy; curettage; metastasis; phototherapy; radiotherapy; squamous cell carcinoma; staging; surgery; surveillance; topical therapy.

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / secondary*
  • Carcinoma, Squamous Cell / therapy*
  • Dermatologic Surgical Procedures*
  • Early Detection of Cancer
  • Humans
  • Mohs Surgery
  • Neoplasm Grading
  • Neoplasm Staging
  • Neoplasms, Second Primary / diagnosis*
  • Neoplasms, Second Primary / prevention & control
  • Radiotherapy
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents